Specifically, MS patients showed a reduction in the number of neurons with nuclear hnRNP A1 and TDP‐43 and a significant increase in the number of neurons with decreased nuclear localization and cytoplasmic mislocalization. This evidence concerns the gene TARDBP and myeloid sarcoma.